However, their mechanisms and benefits make them suitable for different goals
Lawsuits allege that patients who took these peptides suffered severe health issues, including gastrointestinal injuries and other complications
However, many patients prefer oral drug administration compared with alternative delivery routes, likely due to the simplicity and convenience of tablet administration, which could lead to improved compliance [1]
these rare serious effects require emergency evaluation
Comparisons of the primary efficacy outcome, safety outcome, ordinal shift of mRS, mRS 03 and mRS 01 at 90 days were adjusted for a pre-specified set of covariates, including age, premorbid mRS, IVT status, NIHSS on presentation, LKW-to-puncture time, mTICI, and baseline ASPECTS
For groups receiving doxorubicin, the drug was administered intraperitoneally at a dose of 15 mg/kg body weight